3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Unknown
4
Completed
4
Withdrawn
2
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Dermatologic
2
Thoracic
1
Other solid neoplasm
1
Other neoplasm
1
Genitourinary
1
Conditions
Mixed Tumor, Malignant
1
Keratosis
1
Carcinoma, Basal Cell
1
Carcinoma
1
Interventions
Nivolumab
18
Ipilimumab
16
pembrolizumab
15
Cyclophosphamide
13
trametinib
9
Radiotherapy
8
dabrafenib
6
Interleukin-2
6
sargramostim
5
fludarabine phosphate
5
aldesleukin
5
Vemurafenib
5
Peripheral Blood Stem Cell Transplantation
5
Fluorouracil
5
130-nm albumin-bound paclitaxel
5
fludarabine
4
Radiosurgery
4
Melphalan
4
Celecoxib
4
encorafenib
3
durvalumab
3
binimetinib
3
avelumab
3
Vorinostat
3
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Granulocyte-Macrophage Colony-Stimulating Factor
3
Cytarabine
3
Capecitabine
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Withdrawn
×
Tomography, Optical Coherence
×
Dermatologic
×
Clear all
NCT04510727
2024-02-20
Optical Coherence Tomography Guided C&D
University of Miami
Phase NA
Withdrawn
NCT02851693
2019-04-04
OCTSKIN
Centre Hospitalier Universitaire de Saint Etienne
Phase NA
Withdrawn